The American Cancer Society is becoming increasingly concerned about the growing popularity of nicotine pouches.
According to a new study published in the JAMA Network Open, overall sales of nicotine pouches in the United States increased from 2019 to 2022. The data also reveals that sales of products with the highest limit of 8 milligrams of nicotine concentration grew faster than those with lower concentration levels.
We have found that nicotine is a highly addictive substance. The increasing popularity of nicotine pouches could lead to children discovering these products and increase the risk of developing nicotine addiction," said Nigar Nargis, Senior Scientific Director of Tobacco Control Research for the American Cancer Society and lead author of the study. The study, mentioned in a statement, calls for a public health campaign to warn about the potential negative health consequences of nicotine pouches.
The study authors analyzed sales data for four nicotine pouch brands (Zyn, Rogue, On!, and Velo) at 2,182 local trading areas across 48 states and Washington, D.C., including weekly fixed purchase point sales data from August 2019 to March 2022.
According to the results, the overall sales increased from 126.06 million units from August 2019 to December 2019, to 808.14 million units from January 2022 to March 2022.
During the study period, Zyn products led total sales at 58.8%, followed by On products at 24.6%, Velo products at 12.1%, and Rogue products at 4.8%. Zyn product sales peaked in September 2021 and saw a larger increase from October 2021 to March 2022 compared to other brands. However, Rogue products experienced a higher growth rate in sales than any other brand.
2FIRSTS will continue to track and report on this topic, with updates available on the '2FIRSTS APP'. Scan the following QR code to download the app.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
